Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results 2019-02-25 21:00
Texas Cardiac Arrhythmia Institute at St. David's Medical Center enrolling patients to test stroke-reducing device 2019-02-25 10:08
Innovent Organized a Forum Discussing the Pending Launch of its Anti PD-1 Tyvyt® (Sintilimab injection) as Part of the National Mega Innovation Program in Beijing 2019-02-22 15:02
PharmaEssentia and AOP Orphan Receive EU Approval of Besremi™ (Ropeginterferon Alfa-2b) for Treatment of Polycythemia Vera (PV) in EU 2019-02-22 06:13
Foresee Pharmaceuticals Announces Successful Topline Results from Phase 3 Registration Study of LMIS 25 mg in Prostate Cancer 2019-02-21 18:30
Mallinckrodt Announces Interim Analysis Results for Therakos® Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease 2019-02-21 16:00
Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease 2019-02-21 16:00
Cipla and Wellthy Therapeutics Announce Partnership to Offer Digital Therapeutics for Diabetes and Cardiovascular Diseases 2019-02-21 07:30
Takeda, Microsoft and EURORDIS release report with action plan to help rare disease community shorten the diagnostic odyssey 2019-02-20 19:07
Shanghai Concord Medical Cancer Center's Basic Medical Services have been Fully Covered by Medical Insurance 2019-02-20 17:41
ROKIT Healthcare Announces a Novel Application of Dermal Regeneration Platform Using Proprietary Three-Dimensional Bioprinting Strategy 2019-02-20 13:49
Future of Clinical Laboratories: How to Adapt Your Strategy to the Declining Reimbursements and Be Successful 2019-02-19 21:20
Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method 2019-02-19 21:00
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results 2019-02-19 19:00
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results 2019-02-19 19:00
EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo (TM) at WuXi Biologics 2019-02-19 14:21
EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo(TM) at WuXi Biologics 2019-02-19 08:21
Chipscreen Biosciences Announces a Collaboration with Innovent to Evaluate Chidamide and the Combination of Sintilimab, Anti-VEGF Monoclonal Antibody IBI305 in Colorectal Cancer patients 2019-02-18 10:08
Innovent Announces a Collaboration with Chipscreen Biosciences to Evaluate the Combination Therapy in Colorectal Cancer Patients 2019-02-18 08:00
Pivotal Phase III Data for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine 2019-02-18 07:48
1 661 662 663 664 665 964